European biotechs Oxitope Pharma and Arxx Therapeutics have merged to form Calluna Pharma, raising €75m ($81m) in a Series A funding round. Led by existing lead investors Forbion, Sarsia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback